title: [A case of rectal stenosis due to peritoneal dissemination from gastric cancer that was treated with chemoradiation therapy].
abstract: An 82-year-old man underwent total gastrectomy(D2 lymph node dissection)in August 2006. The pathological findings indicated T4a, N3, M0, Stage IIIC gastric cancer, but adjuvant chemotherapy was not initiated. In October 2009, he presented to the hospital with dyschezia. During colonoscopy, the scope could not pass through the colon, thus indicating rectal stenosis. The biopsy findings indicated the presence of signet ring cell carcinoma, which was determined to be due to the peritoneal dissemination from the gastric cancer. To avoid the need for creating a stoma, radiation therapy(2 Gy×20; total dose, 40 Gy)and chemotherapy(weekly paclitaxel and S-1)were initiated. Rectal stenosis was improved and complete remission was maintained until May 2013.
authors.affiliation: Dept. of Gastrointestinal Surgery, Kanagawa Cancer Center.
authors.forename: Junya
authors.initials: J
authors.lastname: Shirai
authors.forename: Haruhiko
authors.initials: H
authors.lastname: Cho
authors.forename: Hirohito
authors.initials: H
authors.lastname: Fujikawa
authors.forename: Kenichi
authors.initials: K
authors.lastname: Iwasaki
authors.forename: Takashi
authors.initials: T
authors.lastname: Ogata
authors.forename: Takaki
authors.initials: T
authors.lastname: Yoshikawa
authors.forename: Akira
authors.initials: A
authors.lastname: Tsuburaya
authors.forename: Ken
authors.initials: K
authors.lastname: Sujishi
authors.forename: Takanobu
authors.initials: T
authors.lastname: Yamada
authors.forename: Tomohiko
authors.initials: T
authors.lastname: Osaragi
authors.forename: Katsuya
authors.initials: K
authors.lastname: Yoneyama
authors.forename: Akio
authors.initials: A
authors.lastname: Kasahara
authors.forename: Yuji
authors.initials: Y
authors.lastname: Yamamoto
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Rino
authors.forename: Munetaka
authors.initials: M
authors.lastname: Masuda
mesh_terms: D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D059248:Chemoradiotherapy; D003251:Constriction, Pathologic / Q000209:etiology; D004338:Drug Combinations; D006801:Humans; D008297:Male; D010094:Oxonic Acid / Q000627:therapeutic use; D017239:Paclitaxel / Q000627:therapeutic use; D010534:Peritoneal Neoplasms / Q000556:secondary / Q000628:therapy*; D012002:Rectal Diseases / Q000209:etiology*; D013274:Stomach Neoplasms / Q000473:pathology / Q000628:therapy*; D005641:Tegafur / Q000627:therapeutic use
chemical_list: D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid; D017239:Paclitaxel